• The FactorFirst card has been revised

    The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...

  • Important CHS survey on gene therapy

    Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best...

  • CHS Board of Directors

    Meet the CHS Board of Directors! From left to right: First row: Cyril Boulila, Wendy Quinn, Leanne Owen. Back row: Dr. Lawrence Jardine, Derek Klatt,...

  • The CHS appoints new CEO

    CLICK HERE to read the official announcement from CHS President, Wendy Quinn.

  • 2021 CHS Annual Report

    Please CLICK HERE to access the 2021 CHS Annual Report. Should you want to consult the complete Financial Statements, you can do so by clicking...

Canadian Hemophilia Society
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.